Literature DB >> 23144209

Call for worldwide withdrawal of tiotropium Respimat mist inhaler.

Richard Beasley, Sonal Singh, Yoon K Loke, Paul Enright, Curt D Furberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23144209     DOI： 10.1136/bmj.e7390

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.

Authors:  Arvind Manoharan; Phillip M Short; William J Anderson; Brian J Lipworth
Journal:  Lung       Date:  2014-06-22       Impact factor: 2.584

Review 2.  Advances in device and formulation technologies for pulmonary drug delivery.

Authors:  John Gar Yan Chan; Jennifer Wong; Qi Tony Zhou; Sharon Shui Yee Leung; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-04-12       Impact factor: 3.246

Review 3.  Emerging role of long acting muscarinic antagonists for asthma.

Authors:  Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 4.  Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; David Price; Klaus F Rabe; Hendrik Schmidt; Norbert Metzdorf; Bartolome Celli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-16

5.  Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study.

Authors:  Francesco Trotta; Roberto Da Cas; Maja Rajevic; Mariangela Rossi; Giuseppe Traversa
Journal:  BMJ Open       Date:  2015-05-25       Impact factor: 2.692

6.  The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods.

Authors:  Peter Kardos; Claus Vogelmeier; Roland Buhl; Carl-Peter Criée; Heinrich Worth
Journal:  BMC Pulm Med       Date:  2015-01-12       Impact factor: 3.317

Review 7.  Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date.

Authors:  Subhabrata Moitra; Arvind B Bhome; Bill B Brashier
Journal:  Drug Des Devel Ther       Date:  2015-04-07       Impact factor: 4.162

8.  Inhaled bronchodilators and acute myocardial infarction: a nested case-control study.

Authors:  Chang-Hoon Lee; Seongmi Choi; Eun Jin Jang; Han-Mo Yang; Ho Il Yoon; Yun Jung Kim; Jimin Kim; Jae-Joon Yim; Deog Kyeom Kim
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

9.  Pharmacotherapies for COPD.

Authors:  Stan Ejiofor; Alice M Turner
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2013-04-25

10.  Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

Authors:  Francesco Trotta; Stefania Spila-Alegiani; Roberto Da Cas; Maja Rajevic; Valentino Conti; Mauro Venegoni; Mariangela Rossi; Giuseppe Traversa
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.